🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

15+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 15 of 15 recruiting trials for “obsolete-idiopathic-hypersomnia-without-long-sleep-time

Phase 3RecruitingNCT07500090

A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)

👨‍⚕️ David Seiden, MD, Harmony Biosciences Management, Inc.📍 12 sites📅 Started Mar 2026View details ↗
RecruitingNCT06732284

Study of Sleep Inertia in Major Depressive Disorder by the Psychomotor Vigilance Task

👨‍⚕️ Elisa EVANGELISTA, CHU de Nimes📍 1 site📅 Started Nov 2025View details ↗
Phase 2RecruitingNCT07096674

A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

🏥 Centessa Pharmaceuticals (UK) Limited📍 14 sites📅 Started Aug 2025View details ↗
NARecruitingNCT07006233

A Novel Approach to Manage Symptoms of Narcolepsy and Idiopathic Hypersomnia

👨‍⚕️ Elizabeth A Machan, PhD, University of Sydney📍 1 site📅 Started Jun 2025View details ↗
Phase 2RecruitingNCT06843590

A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia

👨‍⚕️ Medical Director, Alkermes, Inc.📍 48 sites📅 Started May 2025View details ↗
Phase 2RecruitingNCT06812078

A Study of TAK-360 in Adults With Idiopathic Hypersomnia

👨‍⚕️ Study Director, Takeda📍 29 sites📅 Started Feb 2025View details ↗
Phase 2, PHASE3RecruitingNCT06767683

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

👨‍⚕️ Medical Director, Alkermes, Inc.📍 46 sites📅 Started Jan 2025View details ↗
Phase 2RecruitingNCT06752668

A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

🏥 Centessa Pharmaceuticals (UK) Limited📍 29 sites📅 Started Dec 2024View details ↗
NARecruitingNCT06457945

Mind-wandering and Predictive Processes in Narcolepsy: a Putative Mechanism Through Covert REM Intrusions

👨‍⚕️ Laure PETER-DEREX, Professor, Hospices Civils de Lyon📍 1 site📅 Started Dec 2024View details ↗
NARecruitingNCT06484348

Deciphering the Interactions Between Food Intake, Sleepiness, and Nighttime Sleep Quality in Patients With Type 1 Narcolepsy and Idiopathic Hypersomnia

👨‍⚕️ Laure PETER-DEREX, MD-PhD, Hospices Civils de Lyon📍 2 sites📅 Started Oct 2024View details ↗
Phase 4RecruitingNCT05837091

Low Sodium Oxybate in Patients With Idiopathic Hypersomnia

👨‍⚕️ Chad Ruoff, MD, Mayo Clinic📍 4 sites📅 Started Feb 2024View details ↗
NARecruitingNCT05615584

Spectrometry (MRM) Versus I 125 Radioimmunoassay (RIA) for Quantification of Orexin-A of Patients With Hypersomnolence

🏥 University Hospital, Montpellier📍 1 site📅 Started Feb 2023View details ↗
Enrolling by InvitationNCT05371483

Cardiovascular and Cognitive Implications of Central Disorders of Hypersomnolence and Their Treatments

👨‍⚕️ Chad Ruoff, MD, Mayo Clinic📍 1 site📅 Started May 2022View details ↗
RecruitingNCT05321355

Mainz Register of Patients With Sleep Disorders

🏥 Johannes Gutenberg University Mainz📍 1 site📅 Started Feb 2022View details ↗
RecruitingNCT04330963

International Swiss Primary Hypersomnolence and Narcolepsy Cohort Study

👨‍⚕️ Claudio L Bassetti, Prof., Insel Gruppe📍 1 site📅 Started Jan 2020View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →